 | |
| Clinical data | |
|---|---|
| Other names | L-Tyrosyl-D-penicillamyl-glycyl-L-phenylalanyl-D-penicillamine (2->5)-disulfide; H-Tyr-D-Pen(1)-Gly-Phe-D-Pen(1)-OH |
| Identifiers | |
| |
| CAS Number | |
| PubChemCID | |
| ChemSpider | |
| UNII | |
| ChEBI | |
| ChEMBL | |
| CompTox Dashboard(EPA) | |
| Chemical and physical data | |
| Formula | C30H39N5O7S2 |
| Molar mass | 645.79 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
DPDPE ([D-Pen2,D-Pen5]enkephalin) is asyntheticopioid peptide and aselectiveagonist of theδ-opioid receptor (DOR) which is used inscientific research.[1] It was developed in the early 1980s and was the first highly selective agonist of the DOR to be developed.[1] It was derived fromstructural modification ofmet-enkephalin.[2]
